Proposed Changes to IVDR Would Ease the Use of Precision Diagnostics in Clinical Trials
Advancing Precision Medicine: Emerging Trends in Spatial Biology
FDA Advisory Committee Challenges PD-1 Inhibitor Use in Gastric Cancer: The Rising Importance of PD-L1 Testing
The FDA LDT Rule is No More
SITC 2025
Improving Pathology Precision in Oncology: How AI Reduces Variability in Tumor Percent Assignments